VDJ001

· Beijing VDJBio Co., LTD.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VDJ001, covering 2025-07-09 to 2025-08-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis [Phase 3]